Storage and handling
Other Information Tamper resistant for your protection. Use only if safety seal is intact.
Other Information Tamper resistant for your protection. Use only if safety seal is intact.
HPUS active ingredients
Equal volumes of each ingredient in 10X, 30X, 1LM potencies unless otherwise noted . Abrotanum, Adrenalinum, Adrenocorticotrophin (30X), Alpha-Ketoglutaricum acidum, Alpha-Lipoicum acidum, Baryta carbonica, Calcarea fluorica, Citricum acidum, Coenzyme A, DNA, Ferrum metallicum, Glandula suprarenalis suis, Hekla lava, Helleborus niger, Hypothalamus, Lycopodium clavatum, Oophorinum, RNA, Secale Cornutum, Silicea, Thiaminum hydrochloricum.
Uses a natural aid for premature aging:
Warnings
If pregnant or breast-feeding, ask a healthcare professional
before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center immediately.
Directions
Other Information
Tamper resistant for your protection. Use only if safety seal is intact.
Bio-Energetically Enhanced™ pure
water, citrus extract* (ascorbic
acid, citric acid, citrus aurantium
amara fruit extract, citrus
aurantium sinensis peel extract,
citrus reticulata fruit extract,
demineralized water, glycerin,
lactic acid), Honeysuckle (Lonicera
japonica), polylysine, Shagbark
Hickory (Carya ovata) Bark
Extract, steviol (Steviol
glycosides).
Drug Facts
__________________________________________________________________________________________________________________
HPUS active ingredients Purpose
Equal volumes of each HPUS** ingredient in 10X, 30X, and
1LM potencies unless otherwise noted.
Abrotanum.....................wrinkles, flabby skin, hair loss, stiffness
Adrenalinum ................slow pulse, anemia, high blood pressure
Adrenocorticotrophin (30X) .......pale, thin skin, sexual disorders
Alpha-ketoglutaricum acidum............ constipation, forgetfulness
Alpha-lipoicum acidum ..................mentally jittery, restless sleep
Baryta carbonica ..........memory loss, low libido, muscle cramps
Calcarea fluorica ............................. weak bones, sleeplessness
Citricum acidum...............poor short-term memory, loss of libido
Coenzyme A ................... dry eyes, nose, mouth, throat and skin
DNA.................nervousness, poor concentration, restless sleep
Ferrum metallicum...............................flabby muscles, joint pain
Glandula suprarenalis suis.........................exhaustion, irritability
Hekla lava............................................. gum abscess, toothache
Helleborus niger.............................. dark spots on skin, wrinkles
Hypothalamus ................. indecisiveness, circulatory complaints
Lycopodium clavatum.................. urinary disturbances, hair loss
Oophorinum.................skin disorders, menopause disturbances
RNA..........................low physical strength, stiffness, poor sleep
Secale cornutum ....................shriveled skin, dark spots on face
Silicea.................weak bones, painful hips, legs, knees and feet
Thiaminum hydrochloricum .....................................inflammation
**“HPUS” indicates the active ingredients are in the official
Homeopathic Pharmacopeia of the United States.
Questions? Call 866.298.2740
King Bio, Inc. • 3 Westside Drive
Asheville, NC 28806 USA
FDA Reg. #1053442
For latest product information and
instructions:
www.DrKings.com
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 57955-0250-2 | 2023-04-03 | C162847 | 48780-1 | 9d75b9d0-0025-f424-e053-dadaa90a57ce | Anti Aging and Wrinkles for Women™ |
| 57955-0250-2 | 2022-01-28 | C162847 | 48780-1 | 9d75b9d0-0025-f424-e053-dadaa90a57ce | Anti Aging and Wrinkles for Women™ |
| 57955-8148-2 | 2020-07-09 | C162847 | 48780-1 | 9d75b9d0-0025-f424-e053-dadaa90a57ce | Anti Aging and Wrinkles for Women™ |
| 57955-8148-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-0025-f424-e053-dadaa90a57ce | Anti Aging and Wrinkles for Women™ |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| .ALPHA.-KETOGLUTARIC ACID | ACTIVE INGREDIENT | 8ID597Z82X | 2 | |
| .ALPHA.-LIPOIC ACID | ACTIVE INGREDIENT | 73Y7P0K73Y | 2 | |
| ANHYDROUS CITRIC ACID | ACTIVE INGREDIENT | XF417D3PSL | 2 | |
| ARTEMISIA ABROTANUM FLOWERING TOP | ACTIVE INGREDIENT | QG07G580U0 | 2 | |
| BARIUM CARBONATE | ACTIVE INGREDIENT | 6P669D8HQ8 | 2 | |
| BOS TAURUS HYPOTHALAMUS | ACTIVE INGREDIENT | S6G2NLH4Y7 | 2 | |
| CALCIUM FLUORIDE | ACTIVE INGREDIENT | O3B55K4YKI | 2 | |
| CLAVICEPS PURPUREA SCLEROTIUM | ACTIVE INGREDIENT | 01G9XEA93N | 2 | |
| COENZYME A | ACTIVE INGREDIENT | SAA04E81UX | 2 | |
| CORTICOTROPIN | ACTIVE INGREDIENT | K0U68Q2TXA | 2 | |
| EPINEPHRINE | ACTIVE INGREDIENT | YKH834O4BH | 2 | |
| HEKLA LAVA | ACTIVE INGREDIENT | C21158IIRK | 2 | |
| HELLEBORUS NIGER ROOT | ACTIVE INGREDIENT | 608DGJ6815 | 2 | |
| HERRING SPERM DNA | ACTIVE INGREDIENT | 51FI676N6F | 2 | |
| IRON | ACTIVE INGREDIENT | E1UOL152H7 | 2 | |
| LYCOPODIUM CLAVATUM SPORE | ACTIVE INGREDIENT | C88X29Y479 | 2 | |
| SACCHAROMYCES CEREVISIAE RNA | ACTIVE INGREDIENT | J17GBZ5VGX | 2 | |
| SILICON DIOXIDE | ACTIVE INGREDIENT | ETJ7Z6XBU4 | 2 | |
| SUS SCROFA ADRENAL GLAND | ACTIVE INGREDIENT | 398IYQ16YV | 2 | |
| SUS SCROFA OVARY | ACTIVE INGREDIENT | S7YTV04R8O | 2 | |
| THIAMINE HYDROCHLORIDE | ACTIVE INGREDIENT | M572600E5P | 2 | |
| .ALPHA.-KETOGLUTARIC ACID | ACTIVE MOIETY | 8ID597Z82X | 2 | |
| .ALPHA.-LIPOIC ACID | ACTIVE MOIETY | 73Y7P0K73Y | 2 | |
| ANHYDROUS CITRIC ACID | ACTIVE MOIETY | XF417D3PSL | 2 | |
| ARTEMISIA ABROTANUM FLOWERING TOP | ACTIVE MOIETY | QG07G580U0 | 2 | |
| BARIUM CATION | ACTIVE MOIETY | V645272HLN | 2 | |
| BOS TAURUS HYPOTHALAMUS | ACTIVE MOIETY | S6G2NLH4Y7 | 2 | |
| CLAVICEPS PURPUREA SCLEROTIUM | ACTIVE MOIETY | 01G9XEA93N | 2 | |
| COENZYME A | ACTIVE MOIETY | SAA04E81UX | 2 | |
| COLLOIDAL SILICON DIOXIDE | ACTIVE MOIETY | ETJ7Z6XBU4 | 2 | |
| CORTICOTROPIN | ACTIVE MOIETY | K0U68Q2TXA | 2 | |
| EPINEPHRINE | ACTIVE MOIETY | YKH834O4BH | 2 | |
| FLUORIDE ION | ACTIVE MOIETY | Q80VPU408O | 2 | |
| HEKLA LAVA | ACTIVE MOIETY | C21158IIRK | 2 | |
| HELLEBORUS NIGER ROOT | ACTIVE MOIETY | 608DGJ6815 | 2 | |
| HERRING SPERM DNA | ACTIVE MOIETY | 51FI676N6F | 2 | |
| IRON | ACTIVE MOIETY | E1UOL152H7 | 2 | |
| LYCOPODIUM CLAVATUM SPORE | ACTIVE MOIETY | C88X29Y479 | 2 | |
| SACCHAROMYCES CEREVISIAE RNA | ACTIVE MOIETY | J17GBZ5VGX | 2 | |
| SUS SCROFA ADRENAL GLAND | ACTIVE MOIETY | 398IYQ16YV | 2 | |
| SUS SCROFA OVARY | ACTIVE MOIETY | S7YTV04R8O | 2 | |
| THIAMINE ION | ACTIVE MOIETY | 4ABT0J945J | 2 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | 2 | |
| POTASSIUM SORBATE | INACTIVE INGREDIENT | 1VPU26JZZ4 | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 57955-0250 | 57955-0250-2 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION, CONCENTRATE / IRRIGATION | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | AEROSOL, FOAM / TOPICAL | 1 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, EXTENDED RELEASE / ORAL | 0.2 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRACARDIAC | 1.05 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SYRUP / ORAL | 722 mg/5ml | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / SOFT TISSUE | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SPRAY / NASAL | 9 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET / SUBLINGUAL | 24 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SYSTEM / TOPICAL | 0.2 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION / RESPIRATORY (INHALATION) | 0.03 %w/v | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SYRUP / ORAL | 2 mg/1ml | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRAVENOUS | 2068 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / RESPIRATORY (INHALATION) | 0.13 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER / ORAL | 840 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | PASTE / ORAL | 48 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | POWDER, FOR SUSPENSION / ORAL | 19 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAMUSCULAR | 0.05 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CAPSULE / ORAL | 238 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / RESPIRATORY (INHALATION) | 8 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER, FOR SOLUTION / TOPICAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / SUBCUTANEOUS | 26 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / BUCCAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRA-ARTICULAR | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, EFFERVESCENT / ORAL | 460 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | OINTMENT / TOPICAL | 1 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | GRANULE, FOR SUSPENSION / ORAL | 80 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | GEL / TOPICAL | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | FILM, EXTENDED RELEASE / TRANSDERMAL | 1.38 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SHAMPOO / TOPICAL | 17 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER, FOR SUSPENSION / ORAL | 840 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / TOPICAL | 17 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 385 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | CONCENTRATE / ORAL | 1 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SOLUTION/ DROPS / OPHTHALMIC | 0.47 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET / ORAL | 914 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SHAMPOO, SUSPENSION / TOPICAL | 0.25 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SPRAY, METERED / NASAL | 2 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SWAB / TOPICAL | 0.05 %w/w | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 0.2 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION/ DROPS / ORAL | 19 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION, EXTENDED RELEASE / ORAL | 140.8 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | LOTION / TOPICAL | 0.2 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION/ DROPS / OPHTHALMIC | 0.05 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, EXTENDED RELEASE / ORAL | 45 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CREAM / VAGINAL | 0.49 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | EMULSION / TOPICAL | 0.11 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / PERIDURAL | NA | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET / ORAL | 6 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / EPIDURAL | 0.02 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 608 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER, FOR SOLUTION / ORAL | 315 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / SUBCUTANEOUS | 28 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | EMULSION / OPHTHALMIC | 0.47 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAOCULAR | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRABURSAL | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRAVENOUS | 396 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRAMUSCULAR | 28 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / ORAL | 446 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | AEROSOL, FOAM / RECTAL | 7 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION, CONCENTRATE / INTRAVENOUS | NA |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| d12f16a5-8a09-407b-945a-79b3dda2ceed | 39e191b6-4ece-4c85-bc5d-5ae746e9dd30 | 2023-04-03 | Warnings | 39e191b6-4ece-4c85-bc5d-5ae746e9dd30 |
Adverse event summaries are temporarily unavailable. Other product information remains available.